Questions of medication treatment of constipation of functional origin in children
https://doi.org/10.21518/2079-701X-2015-14-54-58
Abstract
Constipation of functional origin (CFO) is one of the challenges in contemporary pediatrics. Almost every pediatrician constantly has to address the problem in children of all age groups. The main causes for CFO in children are irritable bowel syndrome and functional constipation. Treatment of CFO should be based on a differentiated and integrated approach. The key components of the treatment are osmotic laxatives: lactitol, lactulose, polyethylene glycol.
About the Authors
T. V. Gasilina
Russian Medical Research University named after N.I. Pirogov
Russian Federation
Russian Federation
S. V. Belmer
Russian Medical Research University named after N.I. Pirogov
Russian Federation
Russian Federation
References
1. Хавкин А.И., Файзуллина Р.А., Бельмер С.В. и др. Диагностика и тактика ведения детей с функциональными запорами (Рекомендации общества детских гастроэнтерологов). Вопросы детской диетологии. 2014, 12(4): 49-65.
2. Антропов Ю.Ф. Расстройство механизмов акта дефекации и психический статус детей и подростков. Педиатрия. 2012, 91(4): 25-31.
3. Cremon C, Gargano L, MorseLLi-Labate AM, Santini D, Cogliandro RF, De Giorgio R, StangheLLini V, CorinaLdesi R, Barbara G. Mucosal immune activation in irritabLe boweL syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009, 104: 392-400.
4. Barbara G, StangheLLini V, De Giorgio R, Cremon C, CottreLL GS, Santini D, PasquineLLi G, MorseLLi-Labate AM, Grady EF, Bunnett NW, CoLLins SM, CorinaLdesi R. Activated mast ceLLs in proximity to coLonic nerves correLate with abdominaL pain in irritabLe boweL syndrome. Gastroenterology. 2004, 126: 693-702.
5. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The aLteration of enterochromaffin ceLL, mast ceLL, and Lamina propria T Lymphocyte numbers in irritabLe boweL syndrome and its reLationship with psychoLogicaL factors. J Gastroenterol Hepatol. 2008, 23: 1689-1694.
6. BLagden S, Kingstone T, Soundy A, Lee R, Singh S, Roberts L. A Comparative Study of OuaLity of Life in Persons With IrritabLe BoweL Syndrome and InfLammatory BoweL Disease. Gastroenterol Nurs. 2015 JuL-Aug, 38(4): 268-78.
7. Kovacic K, Sood MR, Mugie S, Di Lorenzo C, Nurko S, Heinz N, PonnambaLam A, BeesLey C, Sanghavi R, SiLverman AH. A muLti-center study on chiLdhood constipation and fecaL incontinence: effects on quaLity of Life. J Pediatr. 2015 Jun, 166(6): 1482-7.e1.
8. Ruiz-Lopez MC, Coss-Adame E. OuaLity of Life in patients with different constipation subtypes based on the Rome III criteria. Rev Gastroenterol Mex. 2015 Jan-Mar, 80(1): 13-20.
9. MiLLer LE, TenniLa J, Ouwehand AC. Efficacy and toLerance of LactitoL suppLementation for aduLt constipation: a systematic review and meta-anaLysis. Clin Exp Gastroenterol. 2014 JuL 12, 7: 241-8.
10. Gordon M, Naidoo K, Akobeng AK, Thomas AG. Cochrane Review: Osmotic and stimuLant Laxatives for the management of chiLdhood constipation (Review). Evid Based Child Health. 2013 Jan, 8(1): 57-109.
11. MueLLer-Lissner SA, WaLd A. Constipation in aduLts. BMJ Clin Evid. 2010 JuL 5, 2010. pii: 0413.
12. DoffoeL M, BertheL M, BockeL R, et aL. Comparative study of LactitoL and LactuLose in the treatment of functionaL constipation in eLderLy subjects. Med Chir Dig 1990, 19: 257-259.
13. Hammer B, RaveLLi GP. Chronic functionaL constipation LactitoL maintenance dose, a muLticentre comparative study with LactuLose. Ther Schweiz 1992, 8: 328-335.
14. HeitLand W, Mauersberger H. Study of the Laxative effect of LactitoL as opposed to LactuLose in an open, randomized comparative study. Schweiz Rundsch Med Prax 1988, 77: 493-495.
15. PitzaLis G, DeganeLLo F, Mariani P, Chiarini-Testa MB, VirgiLii F, Gasparri R, CaLvani L, Bonamico M. LactitoL in chronic idiopathic constipation in chiLdren. Pediatr Med Chir. 1995 May-Jun, 17(3): 223-6.
16. RajaLa SA, SaLminen SJ, Seppanen JH, VapaataLo H. Treatment of chronic constipation with LactitoL sweetened yoghurt suppLemented with guar gum and wheat bran in eLderLy hospitaL in-patients. Compr Gerontol A. 1988 Jun, 2(2): 83-6.
17. Перевалова Ю.В., Цапок П.И. Вопросы питания. Влияние бифидобактерий и содержащих лактитол продуктов на процессы переокисления липидов и кишечную микрофлору. 2008, 77(2): 36-9.
18. Bouhnik Y, Attar A, JoLy FA, Riottot M, Dyard F, FLourie B. LactuLose ingestion increases faecaL bifidobacteriaL counts: a randomised doubLe-bLind study in heaLthy humans. Eur J Clin Nutr. 2004 Mar, 58(3): 462-6.
19. GLeason W., Figueroa-CoLon R., Robinson L.H. et aL. A doubLe-bLind, paraLLeL-group, pLacebo-controLLed study of LactuLose in the treatment of encopresis in chiLdren with chronic constipation. Gastroenterol. 1995; 108 (suppL. 4): A606.
Review
For citations:
Gasilina TV, Belmer SV. Questions of medication treatment of constipation of functional origin in children. Meditsinskiy sovet = Medical Council. 2015;(14):54-58. (In Russ.) https://doi.org/10.21518/2079-701X-2015-14-54-58
Views:
357
Email this article 